Digital Therapeutics Migraine Global Market Report 2025
상품코드:1855861
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
디지털 편두통 치료 시장 규모는 최근 급격히 확대되고 있습니다. 2024년 13억 7,000만 달러에서 2025년에는 16억 9,000만 달러에 달하고, CAGR 23.4%로 확대될 전망입니다. 과거 조사기간 동안의 성장은 편두통의 유병률 증가, 비약물 치료에 대한 수요 증가, 약물을 사용하지 않는 선택에 대한 환자의 선호도 증가, 맞춤 의료에 대한 관심 고조, 디지털 치료에 대한 환급 가용성 확대가 원동력이 되었습니다.
디지털 편두통 치료 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 CAGR 23.3%로 39억 1,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장을 지원하는 것은 웨어러블 신경조절 장치의 채용 확대, 편두통의 예방 의료에 대한 의식 증가, 디지털 헬스를 추진하는 정부의 이니셔티브의 대두, 게임화된 건강 플랫폼에 의한 환자 참여의 강화, 보험사와 디지털 치료 제공업체와의 파트너십 확대 등입니다. 예측 기간의 주요 동향으로는 개인화된 디지털 치료 계획의 진전, 모바일 애플리케이션과 전자 의료 기록의 통합, 원격 의료 기반 편두통 관리 진전, 센서 기반 모니터링 기술 개발, 증거 기반 디지털 치료 개선 등이 있습니다.
디지털 편두통 치료 시장의 확대는 스트레스와 라이프 스타일의 교란 수준 증가에 기인합니다. 스트레스와 라이프 스타일의 변화는 일상적인 압박과 습관이 개인의 심신 건강에 어떤 영향을 미치는지에 관한 것입니다. 이러한 변화는 현대의 직장 환경이나 페이스가 빠른 생활의 요구에 의해 일반화되고 있어, 정신적 부담의 증대나 건강한 일상생활의 방해로 이어집니다. 편두통을 위해 설계된 디지털 치료는 편두통의 발생을 억제하고 전반적인 행복감을 높이기 위해 맞춤형 행동 전략을 제공하고, 잠재적인 요인을 모니터링하며, 더 건강한 습관을 장려함으로써 스트레스와 라이프 스타일 문제에 대한 관리를 지원합니다. 예를 들어, 2024년 2월, 가정용 혈액 검사 서비스를 제공하는 포스 위즈 라이프사가 영국에서 실시한 조사에 의하면, 16세 이상 가운데 거의 5명 중 1명이 일상적으로 스트레스를 느끼고 있었고 남성은 15.3%인 반면, 여성은 24.5%로 높은 비율을 차지하였습니다. 따라서 스트레스 증가와 라이프 스타일 변화가 디지털 편두통 치료 시장의 성장을 가속하고 있습니다.
디지털 편두통 치료 분야의 주요 기업들은 전자 처방 시스템 등의 기술 개발을 통해 환자의 치료를 진행하고 있습니다. 이러한 시스템은 의료 종사자가 디지털 방식으로 처방전을 발행, 전송 및 관리할 수 있게 하여 보다 정확하고, 투약과 관련된 실수를 줄이며, 처방 및 제제 공정의 효율성을 향상시킵니다. 2025년 4월 미국 제약회사 토닉스 파마슈티컬스 홀딩은 편두통 증상 관리를 지원하는 통합 디지털 플랫폼 TONIX ONE을 발표했습니다. 이 플랫폼은 환자의 지식과 셀프 케어 실천을 향상시키는 것을 목표로 하는 맞춤형 도구, 교육 자료 및 지원 서비스를 제공합니다. 또한 사용자가 치료에 적극적으로 참여할 수 있도록 하여 일관된 건강 관리를 촉진합니다. 또한 TONIX ONE은 환자와 건강 관리 제공업체 간의 의사 소통을 강화하고 협력과 전반적인 치료 경험을 향상시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 디지털 편두통 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 디지털 편두통 치료 시장 : 성장률 분석
세계의 디지털 편두통 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 디지털 편두통 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 디지털 편두통 치료 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 디지털 편두통 치료 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
소프트웨어
디바이스
서비스
세계의 디지털 편두통 치료 시장 : 환자 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
성인
소아
세계의 디지털 편두통 치료 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
예방
급성 치료
환자 교육
기타 용도
세계의 디지털 편두통 치료 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
온라인
오프라인
세계의 디지털 편두통 치료 시장 : 최종사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
가정
기타 최종 사용자
세계의 디지털 편두통 치료 시장 세분화 : 소프트웨어 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
모바일 애플리케이션
웹 플랫폼
클라우드 기반 플랫폼
웨어러블 통합 소프트웨어
세계의 디지털 편두통 치료 시장 세분화 : 디바이스 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
웨어러블 디바이스
신경 자극 장치
모니터링 기기
바이오센서
세계의 디지털 편두통 치료 시장 세분화 : 서비스 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
원격 상담 서비스
치료 관리 서비스
환자 지원 서비스
데이터 분석 서비스
제7장 지역별/국가별 분석
세계의 디지털 편두통 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 디지털 편두통 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
디지털 편두통 치료 시장 : 경쟁 구도
디지털 편두통 치료 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Eli Lilly and Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Dr. Reddy's Laboratories Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sword Health : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Biofourmis Inc.
Click Therapeutics Inc.
Sidekick Health
Kaia Health Software GmbH
Salvia BioElectronics
Theranica Bio-Electronics Ltd.
Cefaly Technology SA
Neurolief Ltd.
Aptar Digital Health
NeuroMetrix Inc.
Happify Health
Neura Health
Relivion MG
UpScriptHealth
N1-Headache
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
디지털 편두통 치료 시장(2029년) : 새로운 기회를 제공하는 국가
디지털 편두통 치료 시장(2029년) : 새로운 기회를 제공하는 부문
디지털 편두통 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Digital therapeutics for migraine are evidence-based digital solutions developed to prevent, manage, or treat migraine symptoms through software programs, offering personalized guidance and monitoring to help patients reduce attack frequency and severity. They track triggers and provide real-time feedback to enhance outcomes, complement traditional therapies, and empower patients to actively manage their migraines.
The primary product categories of digital therapeutics for migraine include software, devices, and services. Software consists of digital platforms and applications that deliver evidence-based interventions for migraine management. Patient groups include adults and children, and applications cover prevention, acute treatment, patient education, and more. These products are distributed through both online and offline channels and are utilized by key end-users such as hospitals, clinics, and home care providers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The digital therapeutics migraine market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics migraine market statistics, including the digital therapeutics migraine industry global market size, regional shares, competitors with the digital therapeutics migraine market share, detailed digital therapeutics migraine market segments, market trends, and opportunities, and any further data you may need to thrive in the digital therapeutics migraine industry. This digital therapeutics migraine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The digital therapeutics migraine market size has grown exponentially in recent years. It will grow from $1.37 billion in 2024 to $1.69 billion in 2025 at a compound annual growth rate (CAGR) of 23.4%. The growth during the historic period is driven by the increasing prevalence of migraine, the rising demand for non-drug treatments, the growing patient preference for drug-free options, the heightened focus on personalized healthcare, and the expanding availability of reimbursement for digital therapeutics.
The digital therapeutics migraine market size is expected to see exponential growth in the next few years. It will grow to $3.91 billion in 2029 at a compound annual growth rate (CAGR) of 23.3%. The growth during the forecast period is supported by the increasing adoption of wearable neuromodulation devices, greater awareness of preventive migraine care, the rise of government initiatives promoting digital health, enhanced patient engagement through gamified health platforms, and the growing partnerships between insurers and digital therapeutics providers. Key trends in the forecast period include advancements in personalized digital treatment plans, integration of mobile applications with electronic health records, progress in telemedicine-based migraine care, development of sensor-based monitoring technologies, and improvements in evidence-based digital therapies.
The growing levels of stress and lifestyle disruptions are contributing to the expansion of the digital therapeutics migraine market. Stress and lifestyle changes relate to how everyday pressures and habits affect an individual's physical and mental health. These changes are becoming more common due to the demands of modern work environments and fast-paced living, which lead to increased mental strain and interfere with healthy routines. Digital therapeutics designed for migraine support the management of stress and lifestyle issues by offering tailored behavioral strategies, monitoring potential triggers, and encouraging healthier habits that help reduce the occurrence of migraines and enhance overall well-being. For example, in February 2024, a survey conducted in the United Kingdom by Forthwithlife, a provider of at-home blood testing services, found that nearly one in five individuals aged sixteen and older experiences daily stress, with a higher percentage among women at 24.5 percent compared to 15.3 percent among men. As a result, the rise in stress and lifestyle changes is driving growth in the digital therapeutics migraine market.
Key companies within the digital therapeutics migraine space are advancing patient care through the development of technologies such as electronic prescription systems. These systems allow healthcare professionals to issue, send, and manage prescriptions digitally, offering greater precision, fewer medication-related errors, and improved efficiency in the prescribing and dispensing processes. In April 2025, Tonix Pharmaceuticals Holding Corp., a pharmaceutical company based in the United States, launched TONIX ONE, an integrated digital platform created to assist individuals in managing their migraine condition. This platform offers tailored tools, educational materials, and support services aimed at improving patient knowledge and self-care practices. It also empowers users to take an active role in their treatment, promoting consistent health management. Moreover, TONIX ONE enhances communication between patients and healthcare providers, improving coordination and the overall care experience.
In February 2024, Aptar Digital Health, LLC, a digital health company based in the United States, acquired Healint for an undisclosed sum. This acquisition allows Aptar to broaden its offerings in the field of neurology and strengthen its digital health capabilities. Healint, based in Singapore, provides digital tools for migraine management through its Migraine Buddy application, which uses artificial intelligence and sensor technology to support users in tracking and managing their symptoms.
Major players in the digital therapeutics migraine market are Pfizer Inc., Novartis AG, Eli Lilly and Company, Dr. Reddy's Laboratories Ltd., Sword Health, Biofourmis Inc., Click Therapeutics Inc., Sidekick Health, Kaia Health Software GmbH, Salvia BioElectronics, Theranica Bio-Electronics Ltd., Cefaly Technology S.A., Neurolief Ltd., Aptar Digital Health, NeuroMetrix Inc., Happify Health, Neura Health, Relivion MG, UpScriptHealth, N1-Headache.
North America was the largest region in the digital therapeutics migraine market in 2024. The regions covered in digital therapeutics migraine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the digital therapeutics migraine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The digital therapeutics migraine market consists of revenues earned by entities by providing services such as mobile app-based migraine management services, biofeedback therapy services, wearable device integration services, nutritional guidance services, and remote monitoring programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics migraine market also includes sales of digital apps, and telehealth technology. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Digital Therapeutics Migraine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on digital therapeutics migraine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for digital therapeutics migraine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics migraine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type; Software; Devices; Services
2) By Patient Type; Adult; Pediatric
3) By Application; Prevention; Acute Treatment; Patient Education; Other Applications
4) By Distribution Channel; Online; Offline
5) By End-User; Hospitals; Clinics; Homecare; Other End-Users
Subsegments:
1) By Software; Mobile Application; Web Platform; Cloud-Based Platform; Wearable Integration Software
2) By Devices; Wearable Devices; Neurostimulation Devices; Monitoring Devices; Biosensors
3) By Services; Teleconsultation Services; Therapy Management Services; Patient Support Services; Data Analytics Services
Companies Mentioned: Pfizer Inc.; Novartis AG; Eli Lilly and Company; Dr. Reddy's Laboratories Ltd.; Sword Health; Biofourmis Inc.; Click Therapeutics Inc.; Sidekick Health; Kaia Health Software GmbH; Salvia BioElectronics; Theranica Bio-Electronics Ltd.; Cefaly Technology S.A.; Neurolief Ltd.; Aptar Digital Health; NeuroMetrix Inc.; Happify Health; Neura Health; Relivion MG; UpScriptHealth; N1-Headache
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Digital Therapeutics Migraine Market Characteristics
3. Digital Therapeutics Migraine Market Trends And Strategies
4. Digital Therapeutics Migraine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Digital Therapeutics Migraine Growth Analysis And Strategic Analysis Framework
5.1. Global Digital Therapeutics Migraine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Digital Therapeutics Migraine Market Growth Rate Analysis
5.4. Global Digital Therapeutics Migraine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Digital Therapeutics Migraine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Digital Therapeutics Migraine Total Addressable Market (TAM)
6. Digital Therapeutics Migraine Market Segmentation
6.1. Global Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Devices
Services
6.2. Global Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adult
Pediatric
6.3. Global Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prevention
Acute Treatment
Patient Education
Other Applications
6.4. Global Digital Therapeutics Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online
Offline
6.5. Global Digital Therapeutics Migraine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare
Other End-Users
6.6. Global Digital Therapeutics Migraine Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mobile Application
Web Platform
Cloud-Based Platform
Wearable Integration Software
6.7. Global Digital Therapeutics Migraine Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Wearable Devices
Neurostimulation Devices
Monitoring Devices
Biosensors
6.8. Global Digital Therapeutics Migraine Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Teleconsultation Services
Therapy Management Services
Patient Support Services
Data Analytics Services
7. Digital Therapeutics Migraine Market Regional And Country Analysis
7.1. Global Digital Therapeutics Migraine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Digital Therapeutics Migraine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Digital Therapeutics Migraine Market
8.1. Asia-Pacific Digital Therapeutics Migraine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Digital Therapeutics Migraine Market
9.1. China Digital Therapeutics Migraine Market Overview
9.2. China Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Digital Therapeutics Migraine Market
10.1. India Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Digital Therapeutics Migraine Market
11.1. Japan Digital Therapeutics Migraine Market Overview
11.2. Japan Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Digital Therapeutics Migraine Market
12.1. Australia Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Digital Therapeutics Migraine Market
13.1. Indonesia Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Digital Therapeutics Migraine Market
14.1. South Korea Digital Therapeutics Migraine Market Overview
14.2. South Korea Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Digital Therapeutics Migraine Market
15.1. Western Europe Digital Therapeutics Migraine Market Overview
15.2. Western Europe Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Digital Therapeutics Migraine Market
16.1. UK Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Digital Therapeutics Migraine Market
17.1. Germany Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Digital Therapeutics Migraine Market
18.1. France Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Digital Therapeutics Migraine Market
19.1. Italy Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Digital Therapeutics Migraine Market
20.1. Spain Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Digital Therapeutics Migraine Market
21.1. Eastern Europe Digital Therapeutics Migraine Market Overview
21.2. Eastern Europe Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Digital Therapeutics Migraine Market
22.1. Russia Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Digital Therapeutics Migraine Market
23.1. North America Digital Therapeutics Migraine Market Overview
23.2. North America Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Digital Therapeutics Migraine Market
24.1. USA Digital Therapeutics Migraine Market Overview
24.2. USA Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Digital Therapeutics Migraine Market
25.1. Canada Digital Therapeutics Migraine Market Overview
25.2. Canada Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Digital Therapeutics Migraine Market
26.1. South America Digital Therapeutics Migraine Market Overview
26.2. South America Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Digital Therapeutics Migraine Market
27.1. Brazil Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Digital Therapeutics Migraine Market
28.1. Middle East Digital Therapeutics Migraine Market Overview
28.2. Middle East Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Digital Therapeutics Migraine Market
29.1. Africa Digital Therapeutics Migraine Market Overview
29.2. Africa Digital Therapeutics Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Digital Therapeutics Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Digital Therapeutics Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Digital Therapeutics Migraine Market Competitive Landscape And Company Profiles
30.1. Digital Therapeutics Migraine Market Competitive Landscape
30.2. Digital Therapeutics Migraine Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Sword Health Overview, Products and Services, Strategy and Financial Analysis
31. Digital Therapeutics Migraine Market Other Major And Innovative Companies
31.1. Biofourmis Inc.
31.2. Click Therapeutics Inc.
31.3. Sidekick Health
31.4. Kaia Health Software GmbH
31.5. Salvia BioElectronics
31.6. Theranica Bio-Electronics Ltd.
31.7. Cefaly Technology S.A.
31.8. Neurolief Ltd.
31.9. Aptar Digital Health
31.10. NeuroMetrix Inc.
31.11. Happify Health
31.12. Neura Health
31.13. Relivion MG
31.14. UpScriptHealth
31.15. N1-Headache
32. Global Digital Therapeutics Migraine Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Digital Therapeutics Migraine Market
34. Recent Developments In The Digital Therapeutics Migraine Market
35. Digital Therapeutics Migraine Market High Potential Countries, Segments and Strategies
35.1 Digital Therapeutics Migraine Market In 2029 - Countries Offering Most New Opportunities
35.2 Digital Therapeutics Migraine Market In 2029 - Segments Offering Most New Opportunities
35.3 Digital Therapeutics Migraine Market In 2029 - Growth Strategies
